You just read:

Janssen Demonstrates Strong Commitment to Inflammatory Bowel Disease with Data from 25 Abstracts Presented at the 2019 Digestive Disease Week Annual Meeting

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

May 14, 2019, 08:00 ET